HYPR Hyperfine, Inc.
Healthcare$1.66+11.41%ClosedMarket Cap: $139.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.24
P/S
8.19
EV/EBITDA
-2.43
DCF Value
$-1.31
FCF Yield
-22.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
51.2%
Operating Margin
-226.6%
Net Margin
-226.9%
ROE
-101.3%
ROA
-57.6%
ROIC
-69.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.9M | 50.7% | $-8.6M | $-8.6M | $— | — |
| Q4 null | $5.3M | 50.9% | $-7.7M | $-5.9M | $— | — |
| FY null | $13.6M | 49.8% | $-37.1M | $-35.6M | $— | — |
| Q3 null | $3.4M | 53.8% | $-8.9M | $-11.0M | $— | — |
| Q2 null | $2.7M | 49.3% | $-9.6M | $-9.2M | $— | — |
| Q1 null | $2.1M | 41.3% | $-10.9M | $-9.4M | $— | — |
| Q4 null | $2.3M | 35.6% | $-10.8M | $-10.4M | $— | — |
| FY null | $12.9M | 45.7% | $-43.2M | $-40.7M | $— | — |
| Q3 null | $3.6M | 52.4% | $-11.0M | $-10.3M | $— | — |
| Q2 null | $3.6M | 49.7% | $-10.8M | $-10.2M | $— | — |
| Q1 null | $3.3M | 41.1% | $-10.7M | $-9.8M | $— | — |
| Q4 2023 | $2.7M | 38.5% | $-11.6M | $-10.7M | $-0.15 | — |